{"nct_id":"NCT00903175","title":"Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2009-10","start_date_type":null,"primary_completion_date":"2015-05","primary_completion_date_type":"ACTUAL","completion_date":"2015-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}